RO-0282425

Last updated
RO-0282425
Clinical data
Other namesRO0282425
Routes of
administration 		Unspecified [1]
Drug class Melanocortin MC4 receptor agonist
ATC code
  • None

RO-0282425 is a melanocortin MC4 receptor agonist which was under development for the treatment of erectile dysfunction but was never marketed. [1] [2] Its route of administration was unspecified. [1] The drug was under development by Roche. [1] [2] It reached phase 2 clinical trials by 2005 but its development was subsequently discontinued. [1] [2] The chemical structure of RO-0282425, and whether it is a small molecule or a peptide, do not appear to have been disclosed. [1]

See also

References

  1. 1 2 3 4 5 6 "RO 0282425". AdisInsight. 4 March 2010. Retrieved 27 January 2026.
  2. 1 2 3 "Delving into the Latest Updates on RO-0282425 with Synapse". Synapse. 3 January 2026. Retrieved 27 January 2026.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.